CSC Biomarkers for Early Detection

Detecting cancer at an early stage is critical for improving patient outcomes, and cancer stem cells (CSCs) offer potential biomarkers for early diagnosis. This track focuses on identifying CSC-specific biomarkers, such as surface markers, secreted proteins, and genetic signatures, that can be used to detect cancer at its earliest stages. Researchers investigate how these biomarkers could be used for non-invasive screening, such as liquid biopsies, to monitor disease progression or predict therapeutic response. Early detection of CSCs could lead to more timely and targeted interventions, preventing the development of advanced, treatment-resistant tumors. This research aims to improve cancer prognosis through better diagnostic tools.

    Related Conference of CSC Biomarkers for Early Detection

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    CSC Biomarkers for Early Detection Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in